The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Duloxetine Lilly

60 milligram(s) Gastro-resistant capsule

Eli Lilly Nederland B.V.EU/1/14/972/005-009

Main Information

Trade NameDuloxetine Lilly
Active SubstancesDuloxetine hydrochloride
Strength60 milligram(s)
Dosage FormGastro-resistant capsule
Licence HolderEli Lilly Nederland B.V.
Licence NumberEU/1/14/972/005-009

Group Information



Licence Issued08/12/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0091-127-006
Interchangeable List DocumentPDF of Interchangeable List
« Back